Chronic Kidney Diseases Clinical Trials

34 studies are recruiting for chronic kidney diseases in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 2

1. SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study

   This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.

   Stage

   Not phased

   Ages

   18 and older

   Site

   AKDHC Bullhead City, Bullhead City, Arizona

   Locations

   28 in total

   Run by

   VenoStent

   See if you can join NCT06001827 on ClinicalTrials.gov

2. Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

   Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of r…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Tennessee Health Science Center/Regional One Health, Memphis, Tennessee

   Locations

   2 in total

   Run by

   University of Tennessee

   See if you can join NCT06374277 on ClinicalTrials.gov

3. Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)

   The purpose of this protocol is to treat an intermediate-sized population with chronic kidney disease (CKD) including kidney transplant recipients. The protocol uses allogeneic bone marrow-derived mesenchymal stem cells (MSCs). MSC infusion may be delivered 1) intravenous or 2) intravenous plus int…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Mayo Clinic, Jacksonville, Florida

   Run by

   Mayo Clinic

   See if you can join NCT06752577 on ClinicalTrials.gov

4. Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

   The study seeks to determine if patients with a pre-existing, well-functioning kidney transplant from a HLA-identical living donor can be withdrawn from immunosuppressive medications without compromising allograft function through hematopoietic stem cell (HPSC) infusion from the same donor. HPSC in…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UCLA, Los Angeles, California

   Run by

   University of California, Los Angeles

   See if you can join NCT05525507 on ClinicalTrials.gov

5. Acute Equol Supplementation and Vascular Function in Women With and Without CKD

   The risk of cardiovascular disease (CVD) is significantly elevated in patients with chronic kidney disease (CKD). Notably, women with CKD commonly experience menstrual disturbances induced by CKD, which may contribute to impaired vascular function and elevated CVD risk. However, most of the literat…

   Stage

   Phase 2

   Ages

   50 to 69

   Site

   University of Colorado Anschutz Medical Campus, Aurora, Colorado

   Run by

   University of Colorado, Denver

   See if you can join NCT06128278 on ClinicalTrials.gov

6. Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine

   This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.

   Stage

   Phase 2

   Ages

   21 to 80

   Site

   Brigham and Women's Hospital, Boston, Massachusetts

   Run by

   Brigham and Women's Hospital

   See if you can join NCT04500665 on ClinicalTrials.gov

7. Oral Iron in Children With Chronic Kidney Disease

   This is a pilot clinical trial of oral iron therapy in children with chronic kidney disease (CKD) and mild anemia. Eligible children will be randomized into a standard of care (iron sulfate) arm vs. no iron therapy arm for 3 months. The outcomes will include muscle strength, physical activity, and …

   Stage

   Phase 4

   Ages

   1 to 21

   Site

   Weill Cornell Medicine / New York Presbyterian Hospital, New York, New York

   Locations

   2 in total

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT03991169 on ClinicalTrials.gov

8. Inspiratory Muscle Strength Training in Chronic Kidney Disease

   More than 80% of individuals with chronic kidney disease have concomitant hypertension and the majority fail to achieve blood pressure control <130/80 mmHg, leading to high risk of cardiovascular diseases and end-stage kidney disease. A stepwise combination of lifestyle modifications and drug thera…

   Stage

   Not phased

   Ages

   50 and older

   Site

   University of Colorado - Anschutz Medical Campus, Aurora, Colorado

   Run by

   University of Colorado, Denver

   See if you can join NCT04911491 on ClinicalTrials.gov

9. APOL1 Genetic Testing in African Americans

   Recent breakthroughs in medical genetics have discovered that a portion of kidney failure affecting the Black community is mediated by coding variants in a gene called apolipoprotein L1 (APOL1) - and that genetic variants, not race - account for increased risk. For APOL1 genetic testing to be appli…

   Stage

   Not phased

   Ages

   18 to 90

   Site

   SSM Health Saint Louis University Hospital, St Louis, Missouri

   Run by

   St. Louis University

   See if you can join NCT05656261 on ClinicalTrials.gov